Free Trial

Shuttle Pharmaceuticals (SHPH) SEC Filings & 10K Form

Shuttle Pharmaceuticals logo
$0.39 -0.01 (-1.49%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.38 -0.01 (-3.60%)
As of 03/28/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Shuttle Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/21/2025
7:00 PM
Nabyt Oleh (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/21/2025
7:00 PM
Shuttle Pharmaceuticals (Issuer)
Tung Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/21/2025
7:00 PM
Scorsis George (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
9:51 AM
Shuttle Pharmaceuticals (Filer)
Form PRE 14A
03/13/2025
3:19 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
5:36 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
03/12/2025
5:20 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2025
11:15 PM
Shuttle Pharmaceuticals (Filer)
Form EFFECT
03/05/2025
5:48 AM
Shuttle Pharmaceuticals (Filer)
Form S-1/A
02/28/2025
4:24 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
8:56 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
02/27/2025
8:58 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
02/27/2025
9:00 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
02/27/2025
7:38 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
9:45 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
9:20 AM
Shuttle Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
5:22 AM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/06/2025
6:33 PM
Richards Steven M (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5/A
02/06/2025
6:34 PM
Schafer Joshua (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5/A
02/05/2025
3:55 PM
Brown Milton (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2025
6:30 PM
Richards Steven M (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2025
6:30 PM
Schafer Joshua (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/24/2025
8:39 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
01/23/2025
11:15 PM
Shuttle Pharmaceuticals (Filer)
Form EFFECT
01/21/2025
7:40 PM
Shuttle Pharmaceuticals (Filer)
Form RW
01/21/2025
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
5:37 AM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/07/2025
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:16 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:01 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:57 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
11:05 AM
Shuttle Pharmaceuticals (Filer)
Form 424B4
10/29/2024
11:15 PM
Shuttle Pharmaceuticals (Filer)
Form EFFECT
10/29/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:05 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:49 AM
Shuttle Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
10/25/2024
7:52 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
8:06 AM
Shuttle Pharmaceuticals (Filer)
Form S-1/A
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

10/17/2024
4:17 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:00 PM
Jung Mira (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
5:04 AM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/13/2024
7:25 PM
Shuttle Pharmaceuticals (Filer)
Form 424B3
09/13/2024
4:00 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
4:23 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
3:26 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
8:51 PM
Shuttle Pharmaceuticals (Filer)
Form 10-K/A
09/03/2024
8:52 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q/A
09/03/2024
8:54 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/28/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
5:08 AM
Shuttle Pharmaceuticals (Filer)
Form NT 10-Q
08/07/2024
7:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
8:45 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
3:59 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:42 PM
Lorber Timothy J. (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
5:12 AM
Shuttle Pharmaceuticals (Filer)
Form PRE 14A
05/22/2024
3:15 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
4:01 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
9:05 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:36 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
4:06 PM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners